retatrutide liver damage nonalcoholic fatty disease nash trial Researchers report promising results with retatrutide, which significantly reduced fat in some patients over several months. Excess liver fat causes metabolic dysfunction–associated steatotic Retatrutide the wonder drug: What's

Nature Medicine, 28(10), 2083-2091

Can GLP-1 Medications Cause Diarrhea

Male KKAy mice (10 weeks old) were purchased from Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and maintained in a controlled environment (20 2 C, 5060% humidity) with a 12-h lightdark cycle (lights on at 07:00 and off at 19:00) and free access to water and food

Research has shown that GLP-1 receptors are present in brain regions associated with reward and addiction, such as the nucleus accumbens and the ventral tegmental area

If (a) Tenant breaches such obligation, (b) the presence of Hazardous Materials as a result of such a breach results in contamination of the Property, any portion thereof, or any adjacent property, (c) contamination of the Premises otherwise occurs due to the acts or omissions of a Tenant Party during the Term or any extension or renewal hereof or holding over hereunder, or (d) contamination of the Property occurs as a result of Hazardous Materials that are placed on or under or are released into the Property by a Tenant Party, then Tenant shall indemnify, save, defend (at Landlords option and with counsel reasonably acceptable to Landlord) and hold the Landlord Indemnitees harmless from and against any and all Claims of any kind or nature, including (w) diminution in value of the Property or any portion thereof, (x) damages for the loss or restriction on use of rentable or usable space or of any amenity of the Property, (y) damages arising from any adverse impact on marketing of space in the Property or any portion thereof and (z) sums paid in settlement of Claims that arise before, during or after the Term as a result of such breach or contamination

"These are folks that tend to be left behind." Use among Michigan Medicaid beneficiaries has skyrocketed, quadrupling from 20,935 patients in the 2021 fiscal year to 90,324 in 2024